Takayuki Sakurai

Kanazawa, 9208641, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

High-Dose-Rate Brachytherapy Combined with External Beam Radiotherapy for Newly Defined Very High-Risk and Regional Prostate Cancer: A 17-Year Single-Institution Experience.

High-Dose-Rate Brachytherapy Combined with External Beam Radiotherapy for Newly Defined Very High-Risk and Regional Prostate Cancer: A 17-Year Single-Institution Experience.

Journal: Cancers

Published: January 09, 2026

Comparison of dosimetric characteristics and longitudinal urinary tract symptom changes between high-dose-rate and low-dose-rate brachytherapy combined with external beam radiation therapy for prostate cancer.

Comparison of dosimetric characteristics and longitudinal urinary tract symptom changes between high-dose-rate and low-dose-rate brachytherapy combined with external beam radiation therapy for prostate cancer.

Journal: Brachytherapy

Published: September 29, 2025

Seven-Year PSA ≤ 0.2 ng/mL After High-Dose-Rate Brachytherapy Indicates Eligibility for Discontinuing PSA Surveillance in Prostate Cancer.

Seven-Year PSA ≤ 0.2 ng/mL After High-Dose-Rate Brachytherapy Indicates Eligibility for Discontinuing PSA Surveillance in Prostate Cancer.

Journal: Cancers

Published: August 07, 2025

Biochemical response to neoadjuvant hormonal therapy predicts long-term prostate cancer survival outcomes after high-dose-rate brachytherapy with external beam radiotherapy.

Biochemical response to neoadjuvant hormonal therapy predicts long-term prostate cancer survival outcomes after high-dose-rate brachytherapy with external beam radiotherapy.

Journal: Scientific reports

Published: August 08, 2024

Predicting the survival of patients with painful tumours treated with palliative radiotherapy: a secondary analysis using the 3-variable number-of-risk-factors model.

Predicting the survival of patients with painful tumours treated with palliative radiotherapy: a secondary analysis using the 3-variable number-of-risk-factors model.

Journal: Radiation oncology (London, England)

Published: May 29, 2024

Urinary tract symptoms that should be improved to enhance post-operative urinary quality of life in patients treated with low-dose-rate brachytherapy for prostate cancer: An importance-performance analysis.

Urinary tract symptoms that should be improved to enhance post-operative urinary quality of life in patients treated with low-dose-rate brachytherapy for prostate cancer: An importance-performance analysis.

Journal: Journal of contemporary brachytherapy

Published: December 09, 2023

Notch appearance as a novel radiological predictor of transient expansion and good outcome of expanding schwannoma after radiotherapy.

Notch appearance as a novel radiological predictor of transient expansion and good outcome of expanding schwannoma after radiotherapy.

Journal: Discover oncology

Published: November 16, 2023

Factors Affecting Prostate Displacement During Volumetric Modulated Arc Therapy in Prone Position After High-Dose-Rate Brachytherapy for Prostate Cancer.

Factors Affecting Prostate Displacement During Volumetric Modulated Arc Therapy in Prone Position After High-Dose-Rate Brachytherapy for Prostate Cancer.

Journal: Advances in radiation oncology

Published: January 10, 2023

Patterns of failure in glioblastoma multiforme following Standard (60 Gy) or Short course (40 Gy) radiation and concurrent temozolomide.

Patterns of failure in glioblastoma multiforme following Standard (60 Gy) or Short course (40 Gy) radiation and concurrent temozolomide.

Journal: Japanese journal of radiology

Published: October 19, 2022

Ischemic proctitis after low-dose-rate brachytherapy using hydrogel spacer for prostate cancer.

Ischemic proctitis after low-dose-rate brachytherapy using hydrogel spacer for prostate cancer.

Journal: IJU case reports

Published: February 17, 2022

Prediction of post-radiotherapy survival for bone metastases: a comparison of the 3-variable number of risk factors model with the new Katagiri scoring system.

Prediction of post-radiotherapy survival for bone metastases: a comparison of the 3-variable number of risk factors model with the new Katagiri scoring system.

Journal: Journal of radiation research

Published: August 23, 2021

The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study.

The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study.

Journal: International journal of clinical oncology

Published: May 25, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026